Illumina PT Raised to $147.00 (ILMN)
Stock analysts at ISI Group upped their price objective on shares of Illumina (NASDAQ:ILMN) from $134.50 to $147.00 in a report issued on Wednesday, Analyst Ratings.Net reports. The firm currently has a “neutral” rating on the stock. ISI Group’s target price would indicate a potential upside of 1.71% from the stock’s previous close.
Illumina (NASDAQ:ILMN) opened at 144.53 on Wednesday. Illumina has a 52-week low of $48.00 and a 52-week high of $148.48. The stock has a 50-day moving average of $116.1 and a 200-day moving average of $92.29. The company has a market cap of $18.268 billion and a P/E ratio of 167.36.
Illumina (NASDAQ:ILMN) last released its earnings data on Tuesday, January 28th. The company reported $0.45 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.44 by $0.01. The company had revenue of $387.00 million for the quarter, compared to the consensus estimate of $382.06 million. During the same quarter in the prior year, the company posted $0.42 earnings per share. The company’s quarterly revenue was up 25.1% on a year-over-year basis. On average, analysts predict that Illumina will post $1.78 earnings per share for the current fiscal year.
A number of other firms have also recently commented on ILMN. Analysts at Leerink Swann raised their price target on shares of Illumina from $110.00 to $140.00 in a research note to investors on Friday, January 17th. Separately, analysts at Bank of America Corp. raised their price target on shares of Illumina from $125.00 to $165.00 in a research note to investors on Friday, January 17th. Finally, analysts at Robert W. Baird raised their price target on shares of Illumina from $87.00 to $137.00 in a research note to investors on Friday, January 17th. Seven investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The company has an average rating of “Hold” and an average target price of $118.78.
In other Illumina news, CEO Jay Flatley sold 30,000 shares of Illumina stock in a transaction that occurred on Thursday, January 23rd. The shares were sold at an average price of $142.30, for a total transaction of $4,269,000.00. Following the sale, the chief executive officer now directly owns 399,509 shares of the company’s stock, valued at approximately $56,850,131. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.